510(k) Report

510(k) · Cleared

Cleared

Neurovision JJB System

K072343510(k) TraditionalCleared Oct 29, 200769-day reviewClass II21 CFR 882.1870

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nuvasive, Inc. · GWF Stimulator, Electrical, Evoked Response

Cleared on Oct 29, 2007 as substantially equivalent to K062765 (Nuvasive, Inc., 2007) and 2 other predicates after a 69-day review. Its family tree reaches back 4 generations to 1984.

Decided
Oct 29, 2007
Review
69 days
Class
Class II
Product code
GWF
Recalls
None
Predicates
3

Its longest line of descent runs back 4 generations to K842956 (1984). 10 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK842956 Nicolet VikingNicolet Biomedical Instruments · 1984
  2. 3 generations backK971819 Epoch 2000 Neurological WorkstationAxon Systems, Inc. · 1997
  3. 2 generations backK022785 Epoch XP Neurological Workstation; Epoch XP Lite Neurological…Axon Systems, Inc. · 2002
  4. 1 generation backK032741 Epochxp Neurological Workstation,Epochxp Lite Neurological WorkstationAxon Systems, Inc. · 2003
  5. This deviceK072343 Neurovision JJB SystemNuvasive, Inc. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K842956Nicolet VikingNicolet Biomedical Instruments1984—
−3K971819Epoch 2000 Neurological WorkstationAxon Systems, Inc.1997—
−2K022785Epoch XP Neurological Workstation; Epoch XP Lite Neurological WorkstationAxon Systems, Inc.2002—
−1K032741Epochxp Neurological Workstation,Epochxp Lite Neurological WorkstationAxon Systems, Inc.2003—
0 (this device)K072343Neurovision JJB SystemNuvasive, Inc.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199210
199510
200210
200510
200710
FIG. 1 — Lineage of K072343, 1984–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWF device

  1. #1 K263010 ISIS Headboxes, ISIS Neurostimulator, ISIS…score 17.5 · 19 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062765Modification to Nuvasive Neurovision JJB System
Summary page 1
…e Class: Class LI Classification: §874.1820, §882.1870 Product Code: 77ETN, 84GWF 5 10O(k) Number: K062765 Trade or Proprietary Name: DS7A Constant Current High Voltage Stimulator Manufacturer: Digitimer, L…
Nuvasive, Inc.2007—
*K051357DS7A Constant Current High Voltage Stimulator, Model DS7A; DS7AH Constant Current High…
Summary page 1
…onse Device Class: Class II Classification: §882.1870 Product Code: 84GWF 510O(k) Number: K051357 Page - 2 -…
Digitimer, Ltd.2005—
*K032741Epochxp Neurological Workstation,Epochxp Lite Neurological Workstation
Summary page 2
…Device Class: Class II Classification: §882.1400 Product Code: GWQ, GWE, GWF, GWJ 510(k) Number: K032741 D. Device Description The NeuroVision JJB System consists of a Patient Module, a Control Unit comprised of an…
Axon Systems, Inc.2003—

Also cleared against K062765: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 4.9 years on median.
  • None of the 10 ancestors has a recall.
  • 1 other device also cites its predicate K062765.

How does its category compare?

All GWF devices

GWF Stimulator, Electrical, Evoked Response: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GWF

1in 2025

2007: 32008: 22009: 52010: 32011: 22012: 42013: 32014: 12015: 22016: 12017: 32019: 12020: 12021: 22022: 22023: 22024: 42025: 12026 (partial year): 3
2007high 5 (2009) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWF

92in 2024

2007: 69 days median2009: 178 days median2010: 269 days median2012: 230 days median2013: 174 days median2017: 169 days median2024: 92 days median2026 (partial year): 125 days median
2007high 269 (2010) · low 69 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWF

2so far in 2026, the most since 2007

2012: 12015: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWF

1,034in 2025

2007: 22008: 12009: 12010: 42011: 102012: 442013: 892014: 252015: 222016: 202017: 602018: 582019: 942020: 652021: 552022: 452023: 1502024: 8542025: 1,034
2007high 1,034 (2025) · low 1 (2008)2025

MAUDE reports naming product code GWF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200736902
20082—01
2009517801
2010326904
20112—010
20124230144
20133174089
20141—025
20152—122
20161—020
20173169060
20180—058
20191—094
20201—065
20212—055
20222—045
20232—0150
20244920854
20251—01,034
202631252—

What is it indicated for?

The NeuroVision System is intended for use in the operating room and non-critical care clinical environment for neurological monitoring and status assessment. The System may be used alone or in conjunction with other NuVasive devices to assist in gaining controlled access to the spine.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072343: Neurovision JJB System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K072343

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026